Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
20 pending office actions • 16 art units • 20 examiners • 0 of 20 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
The Governors of the University of Alberta has 21 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 17 distinct art units, showing that the university's research is evaluated by many different specialized groups. The 21 pending office actions represent the current scale of the institution's efforts to secure patent rights.
The prosecution involves 21 distinct examiners, meaning that each pending matter is assigned to a different individual. FAN, WEIHUA is the busiest examiner, though this individual is only responsible for 1 busiest examiner pending actions. This 1 busiest examiner pending actions is the same volume as the actions handled by every other examiner in the group.
Because the 21 pending office actions are distributed among 17 distinct art units, the institution faces a variety of procedural styles. The 21 distinct examiners ensure that no individual has a disproportionate impact on the portfolio. FAN, WEIHUA and the other examiners within the Biotechnology & Pharmaceuticals area provide a decentralized examination process for the university.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (15%) |
| §103 only | 5 (25%) |
| §112 only | 1 (5%) |
| Double-patenting + other | 1 (5%) |
| Multi-statute (no §101) | 10 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FAN, WEIHUA | 1 | 83.3% | +12.7% |
| UTAMA, ROBERT J | 1 | 60.2% | +29.6% |
| REICHERT, RACHELLE LEIGH | 1 | 30.1% | +33.4% |
| BUCKLE JR, JAMES J | 1 | 65.6% | +14.9% |
| GOLOBOY, JAMES C | 1 | 63.7% | +8.7% |
| PROSSER, ALISSA J | 1 | 15.5% | +11.2% |
| KURTZ, BENJAMIN M | 1 | 56.7% | +17.7% |
| OGUNTADE, ELIZABETH BISOLA | 1 | 50.0% | +100.0% |
| FOLEY, SHANON A | 1 | 73.3% | +18.2% |
| JADHAO, SAMADHAN JAISING | 1 | 46.2% | +47.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17625545 | EXONS 45-55 SKIPPING USING MUTATION-TAILORED COCKTAILS OF ANTISENSE MORPHOLINOS IN THE DMD GENE | HUDSON, AMY ROSE | 71d overdue |
| 17886881 | THREE-DIMENSIONAL (3D) HERNIA PLUG DEVICE AND A METHOD OF MANUFACTURING THEREOF | DORNA, CARRIE R | 43d overdue |
| 18691738 | SYNERGISTIC NANOMEDICINE DELIVERING TOPOISOMERASE I TOXIN (SN-38) AND INHIBITORS OF POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE (PNKP) FOR ENHANCED TREATMENT OF COLORECTAL CANCER | PROSSER, ALISSA J | 53d |
| 19162601 | MODIFIED NUCLEIC ACID SEQUENCE FOR CONFERRING CLUBROOT RESISTANCE TO CANOLA AND METHODS OF PRODUCING SAME | FAN, WEIHUA | — |
| 18927536 | METHOD AND SYSTEM FOR USING PHYSICAL TOY BLOCKS TO PREFORM CODING TASKS | UTAMA, ROBERT J | — |
| 18837460 | SYSTEMS AND DEVICES FOR COUPLING METABOLOMICS DATA WITH DIGITAL MONITORS FOR PRECISION HEALTH | REICHERT, RACHELLE LEIGH | — |
| 18737311 | IONIC LIQUID DEMULSIFIERS FOR EMULSION SEPARATION AND BITUMEN DEWATERING | GOLOBOY, JAMES C | — |
| 18440027 | MICROBUBBLE-ENHANCED COLD PLASMA WATER ACTIVATION | KURTZ, BENJAMIN M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691738 | SYNERGISTIC NANOMEDICINE DELIVERING TOPOISOMERASE I TOXIN (SN-38) AND INHIBITORS OF POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE (PNKP) FOR ENHANCED TREATMENT OF COLORECTAL CANCER | PROSSER, ALISSA J | 53d |
| 19162601 | MODIFIED NUCLEIC ACID SEQUENCE FOR CONFERRING CLUBROOT RESISTANCE TO CANOLA AND METHODS OF PRODUCING SAME | FAN, WEIHUA | — |
| 18927536 | METHOD AND SYSTEM FOR USING PHYSICAL TOY BLOCKS TO PREFORM CODING TASKS | UTAMA, ROBERT J | — |
| 18837460 | SYSTEMS AND DEVICES FOR COUPLING METABOLOMICS DATA WITH DIGITAL MONITORS FOR PRECISION HEALTH | REICHERT, RACHELLE LEIGH | — |
| 18799207 | SMART SELF-CENTERED SHEAR WALL SYSTEM | BUCKLE JR, JAMES J | — |
| 18440027 | MICROBUBBLE-ENHANCED COLD PLASMA WATER ACTIVATION | KURTZ, BENJAMIN M | — |
| 18574221 | MIGRATION OF HUMAN PERIPHERAL LEUKOCYTES IN RESPONSE TO CHEMOTACTIC FACTORS DURING PREGNACY | OGUNTADE, ELIZABETH BISOLA | — |
| 18391501 | HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | FOLEY, SHANON A | — |
| Art Unit | Apps |
|---|---|
| 1671 | 2 |
| 1672 | 2 |
| 3646 | 2 |
| 1693 | 2 |
| 1663 | 1 |
| 3715 | 1 |
| 3686 | 1 |
| 3633 | 1 |
| 1771 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19162601 | MODIFIED NUCLEIC ACID SEQUENCE FOR CONFERRING CLUBROOT RESISTANCE TO CANOLA AND METHODS OF PRODUCING SAME | FAN, WEIHUA | 1663 | §101§102§112 | Non-Final OA | — | Pending | Sep 05, 2025 |
| 18927536 | METHOD AND SYSTEM FOR USING PHYSICAL TOY BLOCKS TO PREFORM CODING TASKS | UTAMA, ROBERT J | 3715 | §102§103 | Non-Final OA | — | Pending | Oct 25, 2024 |
| 18837460 | SYSTEMS AND DEVICES FOR COUPLING METABOLOMICS DATA WITH DIGITAL MONITORS FOR PRECISION HEALTH | REICHERT, RACHELLE LEIGH | 3686 | §101§102§112 | Final Rejection | — | Pending | Aug 09, 2024 |
| 18799207 | SMART SELF-CENTERED SHEAR WALL SYSTEM | BUCKLE JR, JAMES J | 3633 | §103 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18737311 | IONIC LIQUID DEMULSIFIERS FOR EMULSION SEPARATION AND BITUMEN DEWATERING | GOLOBOY, JAMES C | 1771 | §102§103§112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18691738 | SYNERGISTIC NANOMEDICINE DELIVERING TOPOISOMERASE I TOXIN (SN-38) AND INHIBITORS OF POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE (PNKP) FOR ENHANCED TREATMENT OF COLORECTAL CANCER | PROSSER, ALISSA J | 1619 | §103§112 | Non-Final OA | 53d | Pending | Mar 13, 2024 |
| 18440027 | MICROBUBBLE-ENHANCED COLD PLASMA WATER ACTIVATION | KURTZ, BENJAMIN M | 1779 | §103§112 | Final Rejection | — | Pending | Feb 13, 2024 |
| 18574221 | MIGRATION OF HUMAN PERIPHERAL LEUKOCYTES IN RESPONSE TO CHEMOTACTIC FACTORS DURING PREGNACY | OGUNTADE, ELIZABETH BISOLA | 1654 | §101§103§112DP | Non-Final OA | — | Pending | Dec 26, 2023 |
| 18391501 | HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | FOLEY, SHANON A | 1671 | §103§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18529858 | HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | JADHAO, SAMADHAN JAISING | 1672 | §103§112DP | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18520057 | E1E2 HCV VACCINES AND METHODS OF USE | ZOU, NIANXIANG | 1671 | §103 | Final Rejection | — | Pending | Nov 27, 2023 |
| 18506083 | SEMICONDUCTOR SYSTEM WITH WAVEGUIDE ASSEMBLY WITH RF SIGNAL IMPREDANCE CONTROLLABLE BY APPLIED ELECTROMAGNETIC RADIATION | MOORE, WHITNEY | 3646 | §102§103Other | Non-Final OA | — | Pending | Nov 09, 2023 |
| 18279517 | THE USE OF EMPAGLIFLOZIN FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §103 | Final Rejection | 46d overdue | Pending | Aug 30, 2023 |
| 18037196 | CYCLOTRON TARGET AND LANTHANUM THERANOSTIC PAIR FOR NUCLEAR MEDICINE | DAVIS, SHARON M | 3646 | §103 | Non-Final OA | 35d overdue | Pending | May 16, 2023 |
| 17800516 | Inhibitors of Human Herpesviruses | ENGLISH, CONNOR KENNEDY | 1625 | §112 | Non-Final OA | — | Pending | Aug 17, 2022 |
| 17886881 | THREE-DIMENSIONAL (3D) HERNIA PLUG DEVICE AND A METHOD OF MANUFACTURING THEREOF | DORNA, CARRIE R | 3791 | §102§103 | Final Rejection | 43d overdue | Pending | Aug 12, 2022 |
| 17625545 | EXONS 45-55 SKIPPING USING MUTATION-TAILORED COCKTAILS OF ANTISENSE MORPHOLINOS IN THE DMD GENE | HUDSON, AMY ROSE | 1636 | §103§112 | Final Rejection | 71d overdue | Pending | Jan 07, 2022 |
| 17596491 | TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF | MARTIN, KEVIN STEPHEN | 1624 | §102§112 | Final Rejection | — | Pending | Dec 10, 2021 |
| 17599282 | XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF | HIBSHMAN, SARAH GRACE | 1693 | §103 | Non-Final OA | — | Pending | Sep 28, 2021 |
| 17187678 | RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-CoV-2 VIRUS | SALVOZA, M FRANCO G | 1672 | §103§112 | Non-Final OA | — | Pending | Feb 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Governors of the University of Alberta has 20 pending office actions as of October 2026, spread across 16 art units and 20 examiners.
Weihua Fan has the most, with 1 of The Governors of the University of Alberta's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
